J Fabre

2.5k total citations · 1 hit paper
46 papers, 1.8k citations indexed

About

J Fabre is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, J Fabre has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in J Fabre's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Metabolism and Genetic Disorders (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). J Fabre is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Metabolism and Genetic Disorders (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). J Fabre collaborates with scholars based in France, United States and Switzerland. J Fabre's co-authors include Alain Rivard, Jeffrey M. Isner, Meredith Magner, Marcy Silver, Marianne Kearney, Dongfen Chen, Takayuki Asahara, Toyoaki Murohara, Peggy Tilly and Jean‐Luc Vonesch and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

J Fabre

44 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Age-Dependent Impairment of Angiogenesis

1999 612 citations Alain Rivard, J Fabre et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Fabre France	22	664	345	329	320	235	46	1.8k
Jesus H. Dominguez United States	26	739 1.1×	123 0.4×	197 0.6×	355 1.1×	229 1.0×	66	2.0k
Miguel Arévalo Spain	24	909 1.4×	161 0.5×	222 0.7×	337 1.1×	237 1.0×	56	2.1k
Domenico Del Principe Italy	26	455 0.7×	189 0.5×	131 0.4×	227 0.7×	175 0.7×	78	1.7k
Joseph A. Jakubowski United States	21	636 1.0×	117 0.3×	254 0.8×	333 1.0×	231 1.0×	43	1.8k
Guido Lazzerini Italy	23	417 0.6×	151 0.4×	397 1.2×	359 1.1×	327 1.4×	50	2.3k
Peter Libby United States	14	395 0.6×	441 1.3×	346 1.1×	266 0.8×	185 0.8×	22	1.7k
Yuichi Fujii Japan	23	492 0.7×	144 0.4×	262 0.8×	475 1.5×	144 0.6×	93	2.0k
François M. Booyse United States	29	577 0.9×	96 0.3×	376 1.1×	241 0.8×	224 1.0×	74	2.1k
J. C. Giddings United Kingdom	30	348 0.5×	105 0.3×	414 1.3×	353 1.1×	231 1.0×	138	3.0k
Kiyoshi Kobayashi Japan	20	343 0.5×	134 0.4×	182 0.6×	307 1.0×	180 0.8×	71	1.3k

Countries citing papers authored by J Fabre

Since Specialization

Citations

This map shows the geographic impact of J Fabre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Fabre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Fabre more than expected).

Fields of papers citing papers by J Fabre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Fabre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Fabre. The network helps show where J Fabre may publish in the future.

Co-authorship network of co-authors of J Fabre

This figure shows the co-authorship network connecting the top 25 collaborators of J Fabre. A scholar is included among the top collaborators of J Fabre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Fabre. J Fabre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Manikpurage, Hasanga D., Marc Dubourdeau, Vincent Baillif, et al.. (2025). Upregulation of the maresin pathway and PGE2 metabolism in the failing human left ventricle. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1870(6). 159645–159645.

2.

Varasteh, Zohreh, Fabien Hyafil, Dévy Diallo, et al.. (2017). Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept. EJNMMI Research. 7(1). 40–40. 32 indexed citations

3.

Tilly, Peggy, et al.. (2015). The receptor EP3 to PGE2: A rational target to prevent atherothrombosis without inducing bleeding. Prostaglandins & Other Lipid Mediators. 121(Pt A). 4–16. 27 indexed citations

4.

Tilly, Peggy, Anne‐Laure Charles, Olivier Meilhac, et al.. (2013). Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence. Cardiovascular Research. 101(3). 482–491. 43 indexed citations

5.

Elverfeldt, Dominik von, Constantin von zur Mühlen, Irene Neudorfer, et al.. (2012). In Vivo Detection of Activated Platelets Allows Characterizing Rupture of Atherosclerotic Plaques with Molecular Magnetic Resonance Imaging in Mice. PLoS ONE. 7(9). e45008–e45008. 14 indexed citations

6.

Fabre, J & Mark E. Gurney. (2009). Limitations of current therapies to prevent thrombosis: a need for novel strategies. Molecular BioSystems. 6(2). 305–315. 28 indexed citations

7.

Tilly, Peggy, et al.. (2007). Vascular wall–produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors. The Journal of Experimental Medicine. 204(2). 311–320. 142 indexed citations

8.

Geary, Cara, et al.. (2005). Increased susceptibility of purinergic receptor-deficient mice to lung infection withPseudomonasaeruginosa. American Journal of Physiology-Lung Cellular and Molecular Physiology. 289(5). L890–L895. 38 indexed citations

9.

Fabre, J, Jennifer L. Goulet, Estelle Riche, et al.. (2002). Transcellular biosynthesis contributes to the production of leukotrienes during inflammatory responses in vivo. Journal of Clinical Investigation. 109(10). 1373–1380. 57 indexed citations

10.

Fabre, J, Jennifer L. Goulet, Estelle Riche, et al.. (2002). Transcellular biosynthesis contributes to the production of leukotrienes during inflammatory responses in vivo. Journal of Clinical Investigation. 109(10). 1373–1380. 5 indexed citations

11.

Fabre, J, MyTrang Nguyen, Kenneth Coggins, et al.. (2001). Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. Journal of Clinical Investigation. 107(5). 603–610. 133 indexed citations

12.

Rivard, Alain, Zhengyu Luo, Harris Perlman, et al.. (1999). Early Cell Loss after Angioplasty Results in a Disproportionate Decrease in Percutaneous Gene Transfer to the Vessel Wall. Human Gene Therapy. 10(5). 711–721. 19 indexed citations

13.

Belle, Éric Van, Luc Maillard, Alain Rivard, et al.. (1998). Effects of Poloxamer 407 on Transfection Time and Percutaneous Adenovirus-Mediated Gene Transfer in Native and Stented Vessels. Human Gene Therapy. 9(7). 1013–1024. 24 indexed citations

14.

Schwarz, Reinhard, et al.. (1980). [Initial aspects of the changes in diabetic proteinuria].. PubMed. 110(8). 295–301. 1 indexed citations

15.

Chauvin, J., et al.. (1978). Le comportement de la gentamicine dans le parenchyme renal. [Behavior of gentamicin in the kidney parenchyma. Studies on rats during and after treatment with therapeutic doses]. IRIS. 1 indexed citations

16.

Fabre, J, et al.. (1978). Nephrotoxicity of gentamicin. Action on subcellular organelles and pharmacokinetics in the kidney.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 10. 53–62. 6 indexed citations

17.

Rudhardt, M, et al.. (1975). Behaviour of Doxycycline in the Tissues. Chemotherapy. 21(1). 8–18. 24 indexed citations

18.

Fabre, J, et al.. (1973). Clinical, ophthalmoscopic and biological findings in systemic fat embolism. Acta Neurochirurgica. 29(1-2). 89–104. 4 indexed citations

19.

Fabre, J, et al.. (1966). Distribution and Excretion of Doxycycline in Man. Chemotherapy. 11(2). 73–85. 52 indexed citations

20.

Fabre, J, et al.. (1954). The Syndrome of Obliteration of the Supra-Aortic Branches. Angiology. 5(1). 39–42. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact